Faculty, Staff and Student Publications
Open-access journal articles from UTHealth GSBS faculty, staff and students.
Submissions from 2024
The Fletcher-Cox Pathway: A Unique View on Clinical Trial Education, Shalini Moningi, Shane Stecklein, Sonal Noticewala, et al.
Targeting MCL1-Driven Anti-apoptotic Pathways Overcomes Blast Progression After Hypomethylating Agent Failure in Chronic Myelomonocytic Leukemia, Guillermo Montalban-Bravo, Natthakan Thongon, Juan Jose Rodriguez-Sevilla, et al.
Differentiation Syndrome Associated With Treatment With IDH2 Inhibitor Enasidenib: Pooled Analysis From Clinical Trials, Pau Montesinos, Amir T Fathi, Stéphane de Botton, et al.
Harnessing Endoscopic Ultrasound-Guided Radiofrequency Ablation to Reshape the Pancreatic Ductal Adenocarcinoma Microenvironment and Elicit Systemic Immunomodulation, Vishali Moond, Bhumi Maniyar, Prateek Suresh Harne, et al.
Comparative Toxicological Assessment of 2 Bisphenols Using a Systems Approach: Evaluation of the Behavioral and Transcriptomic Responses of Danio rerio to Bisphenol A and Tetrabromobisphenol A, Michael G Morash, Morgan W Kirzinger, John C Achenbach, et al.
Toward Clinical-Grade Evaluation of Large Language Models, Amy C Moreno and Danielle S Bitterman
Transcriptomics Analysis Reveals Potential Mechanisms Underlying Mitochondrial Dysfunction and T Cell Exhaustion in Astronauts’ Blood Cells in Space, Maria Moreno-Villanueva, Luis E Jimenez-Chavez, Stephanie Krieger, et al.
Global Statement Defining Interventional Radiology-Have We Reached the Tipping Point?, Robert A Morgan, Parag J Patel, Christoph Binkert, et al.
Phospholipid Metabolic Adaptation Promotes Survival of IDH2 Mutant Acute Myeloid Leukemia Cells, Tatsuya Morishima, Koichi Takahashi, Desmond Wai Loon Chin, et al.
Additional Expression of T-cell Engager in Clinically Tested Oncolytic Adeno-Immunotherapy Redirects Tumor-Infiltrated, Irrelevant T Cells Against Cancer Cells to Enhance Antitumor Immunity, Daisuke Morita, Amanda Rosewell Shaw, Greyson Biegert, et al.
FC Gamma Receptors Promote Antibody-Induced LILRB4 Internalization and Immune Regulation of Monocytic AML, Joshua W Morse, Xun Gui, Mi Deng, et al.
Efficacy of Single-Agent Chemotherapy in Endocrine Therapy-Refractory Metastatic Invasive Lobular Carcinoma, Jason A Mouabbi, Wei Qaio, Yu Shen, et al.
Durable Objective Response to Lurbinectedin in Small Cell Bladder Cancer with TP53 Mutation: A Molecular-Directed Strategy, Mohammad Jad Moussa, Jaanki Khandelwal, Nathaniel R Wilson, et al.
Antiangiogenic Therapy Combined With Immune Checkpoint Blockade in Urothelial Cancer: Systematic Review and Meta-Analysis, Mohammad Jad Moussa, Iuliia Kovalenko, Emanuele Crupi, et al.
IRX4204 Induces Senescence and Cell Death in HER2-Positive Breast Cancer and Synergizes With Anti-HER2 Therapy, Cassandra L Moyer, Amanda Lanier, Jing Qian, et al.
Risk-Benefit Trade-Offs and Precision Utilities in Phase I-II Clinical Trials, Pavlos Msaouel, Juhee Lee, and Peter F Thall
Locoregional Therapies in Immunologically "Cold" Tumors: Opportunities and Clinical Trial Design Considerations, Pavlos Msaouel and Rahul A Sheth
Sample Multiplexing in CyTOF: Path To Optimize Single-Cell Proteomic Profiling, Muharrem Muftuoglu and Michael Andreeff
Inhibition of Lysine Acetyltransferase KAT6 in ER+HER2− Metastatic Breast Cancer: A Phase 1 Trial, Toru Mukohara, Yeon Hee Park, David Sommerhalder, et al.
Association between Antenatal Vaginal Bleeding and Adverse Perinatal Outcomes in Placenta Accreta Spectrum, J Connor Mulhall, Kayla E Ireland, John J Byrne, et al.
Bayesian Optimal Designs for Multi-Arm Multi-Stage Phase II Randomized Clinical Trials with Multiple Endpoints, Guillaume Mulier, Sylvie Chevret, Ruitao Lin, et al.
Bayesian Sequential Monitoring Strategies for Trials of Digestive Cancer Therapeutics, Guillaume Mulier, Ruitao Lin, Thomas Aparicio, et al.
Targeting of CYP2E1 by miRNAs in Alcohol-Induced Intestine Injury, Hyejin Mun, Sungyul Lee, Suyoung Choi, et al.
Endoscopic Hyperspectral Imaging System to Discriminate Tissue Characteristics in Tissue Phantom and Orthotopic Mouse Pancreatic Tumor Model, Na Eun Mun, Thi Kim Chi Tran, Dong Hui Park, et al.
A Bayesian Latent-Subgroup Platform Design for Dose Optimization, Rongji Mu, Xiaojiang Zhan, Rui Sammi Tang, et al.